Breittmayer J P, Bungener M, De The H, Eschwege E, Fougereau M, Guedj G, Kordon C, Philippe O, Postel-Vinay M C, Schaffar-Esterle L
INSERM U.343, Nice, France.
Sci Eng Ethics. 2000 Jan;6(1):41-8. doi: 10.1007/s11948-000-0021-3.
Institutions in France are not yet well prepared to respond to allegations of scientific misconduct. Following a serious allegation in late 1997, INSERM, the primary organization for medical and health-related research in France, began to reflect on this subject, aided by scientists and jurists. The conclusions have resulted in establishing a procedure to be followed in cases of alleged misconduct, and also in reinforcing the application of good laboratory practices within each laboratory. Guidelines for authorship practices and scientific assessment must also be considered. Even though each institution must remain responsible for responding to allegations of scientific misconduct within its doors, INSERM would like to see national, European, and international co-ordination about the methods of such response.
法国的机构尚未做好充分准备来应对科学不端行为的指控。1997年末发生一起严重指控后，法国医学与健康相关研究的主要机构法国国家健康与医学研究院（INSERM），在科学家和法学家的协助下，开始思考这一问题。结论是制定了在被指控行为不端的情况下应遵循的程序，同时加强了每个实验室内部良好实验室规范的实施。还必须考虑作者署名规范和科学评估的指导方针。尽管每个机构必须对其内部的科学不端行为指控负责，但INSERM希望看到在应对此类指控的方法上进行国家、欧洲和国际层面的协调。
